...
首页> 外文期刊>Molecular and Cellular Biochemistry: An International Journal for Chemical Biology >Effect of hepcidin on intracellular calcium in human osteoblasts
【24h】

Effect of hepcidin on intracellular calcium in human osteoblasts

机译:铁调素对人成骨细胞内钙的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Hepcidin is known to increase intracellular iron through binding to and degrading ferroportin, which is a transmembrane protein that transports iron from the intracellular to the outside. However, it is not clear whether hepcidin has a similar effect on intracellular calcium. Here, we investigated the influence of hepcidin on intracellular calcium in human osteoblasts, with or without high environmental iron concentrations. Our data showed that hepcidin (<100 nmol/L) could increase intracellular calcium, and this effect was more significant when cells were exposed to high environmental iron concentrations. To further explore its underlying mechanisms, we pretreated human osteoblasts with Nimodipine, a L-type calcium channel blocker, and Dantrolene, a ryanodine receptor antagonist to inhibit abnormal calcium release from the sarco-endoplasmic reticulum. These treatments had not resulted in any alteration of intracellular calcium in human osteoblasts. Thus, these findings indicate that the increase of intracellular calcium induced by hepcidin is probably due to calcium release from endoplasmic reticulum, which is triggered by calcium influx.
机译:已知铁调素通过与铁转运蛋白结合并降解铁转运蛋白来增加细胞内铁,铁转运蛋白是将铁从细胞内转运到外部的跨膜蛋白。然而,尚不清楚铁调素是否对细胞内钙具有类似作用。在这里,我们研究了铁调素对人成骨细胞中细胞内钙的影响,无论环境铁浓度是否高。我们的数据显示,铁调素(<100 nmol / L)可以增加细胞内钙,当细胞暴露于高环境铁浓度时,这种作用更为明显。为了进一步探讨其潜在机制,我们用L型钙通道阻滞剂Nimodipine和ryanodine受体拮抗剂Dantrolene预处理了人类成骨细胞,以抑制肌钙质网中异常钙的释放。这些治疗并未导致人成骨细胞中细胞内钙的任何改变。因此,这些发现表明,铁调素诱导的细胞内钙的增加可能是由于钙从内质网中释放钙引起的,钙释放是由钙内流触发的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号